The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease

Accumulation and aggregation of amyloid-β (Aβ) peptides in the brain trigger the development of progressive neurodegeneration and dementia associated with Alzheimer’s disease (AD). Perturbation in Aβ clearance, rather than Aβ production, is likely the cause of sporadic, late-onset AD, which accounts...

Full description

Bibliographic Details
Main Authors: Takahisa eKanekiyo, Guojun eBu
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-05-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00093/full
id doaj-dfccb6fbdcb642eea1085937febde611
record_format Article
spelling doaj-dfccb6fbdcb642eea1085937febde6112020-11-24T21:22:10ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652014-05-01610.3389/fnagi.2014.0009392926The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s diseaseTakahisa eKanekiyo0Guojun eBu1Mayo Clinic JacksonvilleMayo Clinic JacksonvilleAccumulation and aggregation of amyloid-β (Aβ) peptides in the brain trigger the development of progressive neurodegeneration and dementia associated with Alzheimer’s disease (AD). Perturbation in Aβ clearance, rather than Aβ production, is likely the cause of sporadic, late-onset AD, which accounts for the majority of AD cases. Since cellular uptake and subsequent degradation constitute a major Aβ clearance pathway, the receptor-mediated endocytosis of Aβ has been intensely investigated. Among Aβ receptors, the low-density lipoprotein receptor-related protein 1 (LRP1) is one of the most studied receptors. LRP1 is a large endocytic receptor for more than 40 ligands, including apolipoprotein E (apoE), α2-macroglobulin and Aβ. Emerging in vitro and in vivo evidence demonstrates that LRP1 is critically involved in brain Aβ clearance. LRP1 is highly expressed in a variety of cell types in the brain including neurons, vascular cells and glial cells, where LRP1 functions to maintain brain homeostasis and control Aβ metabolism. LRP1-mediated endocytosis regulates cellular Aβ uptake by binding to Aβ either directly or indirectly through its co-receptors or ligands. Furthermore, LRP1 regulates several signaling pathways, which also likely influences Aβ endocytic pathways. In this review, we discuss how LRP1 regulates the brain Aβ clearance and how this unique endocytic receptor participates in AD pathogenesis. Understanding of the mechanisms underlying LRP1-mediated Aβ clearance should enable the rational design of novel diagnostic and therapeutic strategies for AD.http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00093/fullApolipoproteins EEndocytosisSignal TransductionAlzheimer’s diseaseLRP1degradation
collection DOAJ
language English
format Article
sources DOAJ
author Takahisa eKanekiyo
Guojun eBu
spellingShingle Takahisa eKanekiyo
Guojun eBu
The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
Frontiers in Aging Neuroscience
Apolipoproteins E
Endocytosis
Signal Transduction
Alzheimer’s disease
LRP1
degradation
author_facet Takahisa eKanekiyo
Guojun eBu
author_sort Takahisa eKanekiyo
title The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
title_short The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
title_full The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
title_fullStr The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
title_full_unstemmed The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
title_sort low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in alzheimer’s disease
publisher Frontiers Media S.A.
series Frontiers in Aging Neuroscience
issn 1663-4365
publishDate 2014-05-01
description Accumulation and aggregation of amyloid-β (Aβ) peptides in the brain trigger the development of progressive neurodegeneration and dementia associated with Alzheimer’s disease (AD). Perturbation in Aβ clearance, rather than Aβ production, is likely the cause of sporadic, late-onset AD, which accounts for the majority of AD cases. Since cellular uptake and subsequent degradation constitute a major Aβ clearance pathway, the receptor-mediated endocytosis of Aβ has been intensely investigated. Among Aβ receptors, the low-density lipoprotein receptor-related protein 1 (LRP1) is one of the most studied receptors. LRP1 is a large endocytic receptor for more than 40 ligands, including apolipoprotein E (apoE), α2-macroglobulin and Aβ. Emerging in vitro and in vivo evidence demonstrates that LRP1 is critically involved in brain Aβ clearance. LRP1 is highly expressed in a variety of cell types in the brain including neurons, vascular cells and glial cells, where LRP1 functions to maintain brain homeostasis and control Aβ metabolism. LRP1-mediated endocytosis regulates cellular Aβ uptake by binding to Aβ either directly or indirectly through its co-receptors or ligands. Furthermore, LRP1 regulates several signaling pathways, which also likely influences Aβ endocytic pathways. In this review, we discuss how LRP1 regulates the brain Aβ clearance and how this unique endocytic receptor participates in AD pathogenesis. Understanding of the mechanisms underlying LRP1-mediated Aβ clearance should enable the rational design of novel diagnostic and therapeutic strategies for AD.
topic Apolipoproteins E
Endocytosis
Signal Transduction
Alzheimer’s disease
LRP1
degradation
url http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00093/full
work_keys_str_mv AT takahisaekanekiyo thelowdensitylipoproteinreceptorrelatedprotein1andamyloidbclearanceinalzheimersdisease
AT guojunebu thelowdensitylipoproteinreceptorrelatedprotein1andamyloidbclearanceinalzheimersdisease
AT takahisaekanekiyo lowdensitylipoproteinreceptorrelatedprotein1andamyloidbclearanceinalzheimersdisease
AT guojunebu lowdensitylipoproteinreceptorrelatedprotein1andamyloidbclearanceinalzheimersdisease
_version_ 1725997156291051520